Matrine suppresses liver cancer progression and the Warburg effect by regulating the circROBO1/miR‐130a‐5p/ROBO1 axis

Abstract

AbstractMatrine, an effective component extracted from the traditional Chinese herb, Sophora flavescens, has been indicated to exert antitumor activity in different types of cancer. However, the role and precise mechanism of matrine in the progression of liver cancer remains largely unclear. Cell viability, cell proliferation, cell apoptosis, and Warburg effect were estimated by cell counting kit‐8 assay, colony formation assay, flow cytometry assay, and glucose uptake and lactate production assay, respectively. The candidate Circular RNAs (circRNAs) were screened by integrating the Gene Expression Omnibus database (GSE155949) analysis with the online program GEO2R. A quantitative real‐time polymerase chain reaction was employed to test the expression of circRNA circROBO1, microRNA miR‐130a‐5p, and roundabout homolog 1 (ROBO1). The interaction of circROBO1/miR‐130a‐5p/ROBO1 axis was predicted and confirmed by bioinformatics analysis, a dual‐luciferase reporter assay, and an RNA pull‐down assay. A xenograft mouse model was employed to reveal the role of matrine in vivo. Matrine repressed liver cancer cell viability, proliferation, and Warburg effect, but increased cell apoptosis in vitro. CircROBO1 and ROBO1 were upregulated, but miR‐130a‐5p was downregulated in liver cancer tissues. Additionally, matrine could reduce the expression of circROBO1 and ROBO1, and increase the expression of miR‐130a‐5p. Mechanically, overexpression of circROBO1 partly recovered the effect of matrine on liver cancer cell viability, proliferation, apoptosis, and Warburg effect by regulating the miR‐130a‐5p/ROBO1 axis. Matrine impeded liver cancer development by mediating the circROBO1/miR‐130a‐5p/ROBO1 axis, which provided a theoretical basis for the application of matrine as an effective anticancer drug for liver cancer.